Cell senescence in liver diseases: pathological mechanism and theranostic opportunity
The DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.
Abstract
The liver is not oblivious to the passage of time, as ageing is a major risk factor for the development of acute and chronic liver diseases. Ageing produces alterations in all hepatic cells, affecting their phenotype and function and worsening the prognosis of liver disease. The ageing process also implies the accumulation of a cellular state characterized by a persistent proliferation arrest and a specific secretory phenotype named cellular senescence. Indeed, senescent cells have key roles in many physiological processes; however, their accumulation owing to ageing or pathological conditions contributes to the damage occurring in chronic diseases. The aim of this Review is to provide an updated description of the pathophysiological events in which hepatic senescent cells are involved and their role in liver disease progression. Finally, we discuss novel geroscience therapies that could be applied to prevent or improve liver diseases and age-mediated hepatic deregulations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cellular senescence, a stress-induced program causing stable cell-cycle arrest, is a hallmark of liver aging, fibrosis, and cancer.”
From Cellular senescence in human liver under normal aging and cancer (2026) · cites this paper as [3]
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 1×
“This type of cancer is primarily associated with risk factors such as HBC and HCV infections, excessive alcohol consumption and obesity, which substantially contribute to its pathogenesis 136 .”
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 5×
“Conversely, HSCs lacking functional p53 secrete specific factors that facilitate the polarization of macrophages towards a tumour-promoting phenotype through the secretion of IL-33, therefore enhancing the proliferation of premalignant cells 93–95 .”
InfluentialHallmarks of aging: An expanding universe
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023) · Cell · doi:10.1016/j.cell.2022.11.001 · Cited by 6,549 · cited 1×
“…of TP53 (coding for p53) and different cyclin-dependent kinase (CDK) inhibitors, such as p16 and p21, which results in persistent activation of the retinoblastoma family proteins and the inhibition of transcriptional activators (E2F family) that are required for cell cycle progression 19,20 .”
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 3×
“As described above, SASP encompasses a multitude of factors released by senescent cells, including cytokines, chemokines, interleukins and growth factors, such as IL-1, IL-6, C-C motif chemokine ligand 2 (CCL2) and insulin-like growth factor, among others 24 .”
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 6×
“Certainly, within the spectrum delineated by these two contrasting conditions, actively dividing cells can transition into alternative states, including cellular senescence 1 .”
InfluentialMechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · cited 1×
“Notably, this contradicts what is observed during liver dysfunction, in which the loss of lipid droplets is a characteristic of HSC activation 89 .”
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818 · cited 4×
“…of MASLD in HFD-fed mice through the hepatic accumulation of so-called albumosomes — spherical shell-like structures in the cytoplasm formed by prefolding albumin — which can trap prefolding carnitine palmi-toyltransferase 2 thereby maintaining mitochondrial homeostasis from exhaustion 149 .”
Influential
Cited by
Metabolic reprogramming in liver fibrosis
Horn, P., & Tacke, F. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.003 · Cited by 432
Metformin decelerates aging clock in male monkeys
Yang, Y., Lu, X., Liu, N., Ma, S., Zhang, H., Zhang, Z., Yang, K., Jiang, M., Zheng, Z., Qiao, Y., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.021 · Cited by 227
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
Macrophages: Subtypes, Distribution, Polarization, Immunomodulatory Functions, and Therapeutics
Peng, M., Li, N., Wang, H., Li, Y., Liu, H., Luo, Y., Lang, B., Zhang, W., Li, S., Tian, L., et al. (2025) · MedComm · doi:10.1002/mco2.70304 · Cited by 122
Couteur, D. G. L., Ngu, M., Hunt, N. J., Brandon, A. E., Simpson, S. J., & Cogger, V. C. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01099-z · Cited by 89
“Cellular senescence Ageing 19,112,245 Cellular senescence detected in all liver cell types, including hepatocytes HCC 6,246 Senescence is protective against HCC initiation by reducing cellular proliferation Secretion of inflammatory cytokines (SASP) contributes to inflammation in chronic liver…”
Regulation of Hepatic Stellate Cell Phenotypes in Metabolic Dysfunction–Associated Steatohepatitis
Kisseleva, T., Ganguly, S., Murad, R., Wang, A., & Brenner, D. A. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.03.010 · Cited by 85
Du, K., Umbaugh, D. S., Wang, L., Jun, J. H., Dutta, R. K., Oh, S., Ren, N., Zhang, Q., Ko, D. C., Ferreira, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57616-w · Cited by 67
Cellular senescence in liver diseases: From molecular drivers to therapeutic targeting
Du, K., Umbaugh, D. S., Ren, N., & Diehl, A. M. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.08.021 · Cited by 47
PGLYRP2 drives hepatocyte-intrinsic innate immunity by trapping and clearing hepatitis B virus
Li, Y., Ma, H., Zhang, Y., He, T., Li, B., Ren, H., Feng, J. F., Sheng, J., Li, K., Yu, Q., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188083 · Cited by 41
“More-over, hepatocytes are essential in orchestrating systemic innate immunity, secreting innate immune molecules whose activity and effectiveness are markedly influenced by age (16–20).”
Felli, É., Nulan, Y., Ortega‐Ribera, M., Fernández‐Iglesias, A., & Gracia‐Sancho, J. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.10.017 · Cited by 38
Self-citationSenescence landscape in the liver following sepsis and senolytics as potential therapeutics
Lavarti, R., Cai, L., Alvarez‐Diaz, T., Medina‐Rodriguez, T., Bombin, S., & Raju, R. P. (2024) · Aging Cell · doi:10.1111/acel.14354 · Cited by 31
“…can significantly alter the microenvironment and tissue homeostasis, and has been shown to promote metabolic dysfunction of paranchymal and non-paranchymal cells leading to increased vascular resistance, portal hypertension, steatotic liver disease, and cirrhosis (Sanfeliu-Redondo et al., 2024).”
Involvement of SIRT1-mediated aging in liver diseases
Zhang, Y., Gong, C., Tao, L., Zhai, J., Huang, F., & Zhang, S. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1548015 · Cited by 31
Iron chelation as a new therapeutic approach to prevent senescence and liver fibrosis progression
Amengual, J., Alay, A., Vaquero, J., Gonzalez‐Sanchez, E., Bertrán, E., Sánchez, A., Herrera, B. M., Meyer, K. R., Maus, M., Serrano, M., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07063-0 · Cited by 29
“The major contributors to senescence properties in the liver are hepatocytes [39].”
Gold, N. M., Ding, Q., Yang, Y., Pu, S.-Y., Cao, W., Ge, X., Yang, P., Okeke, M. N., Nisar, A., Pan, Y., et al. (2025) · MedComm · doi:10.1002/mco2.70086 · Cited by 22
Tissue regeneration: Unraveling strategies for resolving pathological fibrosis
Li, J., Wang, S., Yuan, J., Mao, X., Wang, X., Zhang, L., Dong, Q., Chen, Z., Wang, Y., & Tang, N. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.10.002 · Cited by 23
Lu, P., Zhou, H., Xu, X., Long, Y., Jiang, J., & Wang, F. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c03498 · Cited by 21
Lou, C., Lan, T., Xu, S., Hu, X., Li, J., Xiang, Z., Lin, S., Fan, X., Chen, J., & Xu, X. (2025) · Gut · doi:10.1136/gutjnl-2025-334763 · Cited by 20
“167 168 In homeostatic regeneration, the renewal of necroptotic hepatocytes is derived from self-replication of hepatocytes.”
Polyploidy-mediated resilience in hepatic aging: molecular mechanisms and functional implication
Addissouky, T. A. (2024) · Egyptian Liver Journal · doi:10.1186/s43066-024-00391-y · Cited by 20
“They also exhibit persistent DNA damage response signaling, indicating ongoing genomic stress [47, 48].”
Beyond M1/M2: The role of reactive oxygen species in liver fibrosis and immune modulation
Lu, H., Huang, J., Wang, Y.-C., Casals, E., Casals, G., & Zeng, M. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103933 · Cited by 19
“Similarly, senescence-associated macrophages (SAMs), identified by CD36 and p16INK4a, contribute to ECM remodelling by producing MMP-12, despite their role in clearing senescent HSCs [90,91].”
Vu, H., Sun, Y., Xiong, Z., Tan, X., Radford‐Smith, D. E., Causer, A., Dickens, A. M., Hyötyläinen, T., Evstafev, I., Orešič, M., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101657 · Cited by 20
Zhao, Q., Lu, S., Guan, Y., Sun, Z., Qiu, S., & Zhang, A. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02867-9 · Cited by 17
“Stressed hepatocytes and activated HSCs can undergo senescence, adopting a senescence-associated secretory phenotype (SASP) [202].”
Senotherapeutic repurposing of metformin for age-related diseases and their signaling pathways
Turgut, Ş., Atasever, E., Cebe, T., Andican, G., & Çakatay, U. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10524-0 · Cited by 16
Song, Y.-J., Hu, Z.-Y., Yu, Q., Lou, M., Cheng, Y., Chen, M.-S., Wang, J.-X., Jiang, F.-W., Huang, Y.-F., Zheng, J., et al. (2025) · Research · doi:10.34133/research.1090 · Cited by 14
“Impaired cell proliferation is a main feature of cellular senescence [ 43 ].”
Reviewing the function of macrophages in liver disease
Chen, L., Guillot, A., & Tacke, F. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2508963 · Cited by 16
“In the early stages of HCC development, cellular senescence, a stress response characterized by accumulated DNA damage, cell cycle arrest and the release of inflammatory cytokines, is the main feature of pre-malignant hepatocytes [132].”
Aging and Aging-Related Senescence in Liver
Ganguly, S., Sakane, S., Hokutan, K., Zhang, V., Miciano, C., Wang, A., Brenner, D. A., & Kisseleva, T. (2025) · Seminars in Liver Disease · doi:10.1055/a-2637-2549 · Cited by 14
“88 They undergo metabolic alterations including higher lipid and glucose uptake, with increased expression of genes involved in cholesterol uptake and synthesis and, at the same time, deregulation of glucose transporter GLUT2 and GLUT4 expression, altogether affecting key metabolic pathways.”
Cellular senescence in human liver under normal aging and cancer
Karpova, A., Li, X., Peng, C.-W., Gallant, K. L., Rapp, D. R., Alligood, D. M., Houston, A. J., Park, A., Targino da Costa, A. L. N., Chou, W.-H., et al. (2026) · Cell Genomics · doi:10.1016/j.xgen.2025.101133 · Cited by 13
Systemic and metabolic control of liver regeneration
Deng, Y., Zhao, Z., Sun, Y., & Ma, L. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.09.008 · Cited by 10
Liu, J., Song, Q., Li, C., Yan, J., An, N. A., Yin, W., Diao, J., Su, Y., & Wang, Y. (2025) · Cell Proliferation · doi:10.1111/cpr.70087 · Cited by 8
He, K., Wei, D., Liu, Q., Liu, X., Zhou, D., Chen, S., Zhu, D., & Xu, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-78183-y · Cited by 7
“Cellular senescence occurs in chronic liver diseases, liver cancers, and cholangiopathies 22,23 .”
BackgroundHanna, S., Sethiadi, J., Ali, Q., & Sinha, S. (2025) · Cancers · doi:10.3390/cancers17162600 · Cited by 7
“These changes include expanded hepatic zones, reduced regenerative capacity, increased oxidative stress, mitochondrial dysfunction, and chronic low-grade inflammation, all of which contribute to liver vulnerability in older individuals [5,6] (Figure 1).”
Piva, M., Martelossi-Cebinelli, G., Mendes-Pierotti, S., Chinen, W. H., Cardines, P. H. F., Martinez, R. M., Georgetti, S. R., Baracat, M. M., Vicentini, F. T. M. C., Verri, W. A., Jr., et al. (2026) · Foods · doi:10.3390/foods15122159 · Cited by 7
Influencing factors and mechanism of hepatocyte regeneration
Zhang, X., Li, S., Hao, L., Jia, F., Yu, F., & Hu, X. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06278-9 · Cited by 7
Capsaicin and TRPV1: A Novel Therapeutic Approach to Mitigate Vascular Aging
Cui, X.-Y., & Zhan, J. (2025) · Aging and Disease · doi:10.14336/ad.2024.1292 · Cited by 6
“Senescent cells elicit a sophistcated pro-inflammatory response termed as SASP, which comprises a series of pro-inflammatory cytokines [16].”
Delaying liver aging: Analysis of structural and functional alterations
Yao, Y., Cao, Q.-Y., & Li, Z. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i15.103773 · Cited by 6
Priego-Parra, B. A., Román-Calleja, B. M., Gallego‐Durán, R., Gracia‐Sancho, J., Velasco, J. A. V.-R., & Remes-Troche, J. M. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i7.107668 · Cited by 6
Self-citationRen, K., Peng, Y.-P., Chen, H., Wang, X., Min, T., Ma, Y., Deng, X., Tong, S., Liu, Y., Zhang, Y., et al. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.141085 · Cited by 6
Aoshima, K., & Tanimizu, N. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.04.008 · Cited by 7
“To understand why the transition from BLPC2 to hepatocytes is limited in mouse chronic injury models, attention has been drawn to hepatocyte senescence, a key feature of human chronic liver disease [51,52], which indicates that hepatocytes have lost their proliferative capacity [53].”
Liver quad culture chip as a model for radiation injury research
Ueda, Y., Omiya, S., Pinney, J. J., Bylicky, M. A., & Aryankalayil, M. J. (2025) · Scientific Reports · doi:10.1038/s41598-025-96140-1 · Cited by 5
“DNA damage and cellular senescence of hepatocytes and NPCs induce various biological changes such as metabolic dysfunction, inflammation, endothelial dysfunction and HSCs activation in the liver 49 .”
Lipophagy in immune cells and immune response modulation: Mechanisms and therapeutic potential
Shang, Y., Yuan, J., Wang, S., He, W., Wang, B., Zheng, D., Yang, N., Jin, J., & He, Q. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115172 · Cited by 5
cGAS-STING signaling pathway in MASLD and liver fibrosis
Xiao, Y., Ma, Y., Gan, C., Huang, Z., & Gao, J. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-025-02612-2 · Cited by 5
p16 Ink4a ‐Positive Hepatocytes Drive Liver Fibrosis Through Activation of LIFR Family Pathway
Nishikawa, K., Wang, T., Kawakami, S., Tanimoto, S., Yamaguchi, K., Kido, T., Kimura, M., Hishima, T., Okamura, Y. T., Omori, S., et al. (2026) · Advanced Science · doi:10.1002/advs.202510562 · Cited by 5
“This idea is strongly supported by observations that mouse Tom + hepatocytes in CCl 4 -induced liver injury expressed significantly higher levels of p16 Ink4a mRNA and that much higher numbers of p16 Ink4a + hepatocytes were detected in human liver samples from cirrhotic patients [ 11, 14 ].”
Shi, J., Hou, Z., Fan, L., Chen, H., Ma, N., & Huang, E. (2024) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-24-792 · Cited by 5
Tang, W., Zhang, Q., Qin, L., Yang, X., Chu, D., Li, H., Zhang, J., Zhang, Y., & Zhang, H. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157089 · Cited by 5
Pinto, A. P., Muñoz, V. R., Tavares, M. E. A., Neto, I. V. D. S., dos Santos, J. R., Rodrigues, G. S., Carolino, R. O. G., Alberici, L. C., Simabuco, F. M., Teixeira, G. R., et al. (2024) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.70001 · Cited by 4
“10 Clinical studies have shown that the prevalence of NAFLD is 16% higher in older adults than in younger individuals.”
Mitochondrial dysfunction-mediated hepatocyte senescence is involved in cholestatic liver injury
Tong, C.-C., Xue, Y.-F., He, X., Shen, X., Wang, H., & Chen, X. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.08.006 · Cited by 4
Sagar, P., Perumal, S. K., Ramachandran, R., Bellamkonda, R., Mahalingam, S., Osna, N. A., Rasineni, K., & Kharbanda, K. K. (2025) · Biomolecules · doi:10.3390/biom15121727 · Cited by 4
“While the liver demonstrates remarkable resilience during aging, hepatic cells do undergo cellular changes characteristic of aging that adversely affect their phenotype and function [5].”
Rate and clinical predictors of skeletal muscle loss in patients with cirrhosis
Yang, T., Ha, N. B., Fan, B., Barry, F., Seetharaman, S., Cho, B., Czepiel, K. S., Sharma, A., Usman, L., & Lai, J. C. (2026) · Gut · doi:10.1136/gutjnl-2026-339159 · Cited by 4
Zhu, Y., Wei, D., Karin, M., & Gu, L. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70293 · Cited by 4
“…the accumulation of senescent cells during old age was proposed to enhance tumour-promoting smouldering inflammation through the senescence-associated secretory phenotype, 11 the FBP1-NRF2 crossregulatory interactions described above seem to play a more critical role in MASH to HCC progression.”
Supramolecular carrier-free biological nanofibers for treatment of liver fibrosis
Jiang, C., Li, B., Xu, Z., Li, X., Li, H., & Zou, Q. (2025) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2025.138791 · Cited by 3
Ogbu, C. E., Ogbu, S. C., Ogbu, C. P., & Umerah, C. (2026) · iLiver · doi:10.1016/j.iliver.2026.100222 · Cited by 3
“Practical strategies could include curated SASP panels from proteomic resources, inclusion of GDF15 (which correlates with NAFLD severity), and, where feasible, tissue epigenetic age measures as mechanistic readouts 84-86 .”
Recycling senescent cell lipids for targeted senotherapy
Ji, X., He, X., Cai, H., Tang, P., Zhou, H., Wang, J., Wu, Y., Zhou, J., Lin, Z., Xu, K., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70486-0 · Cited by 3
Huang, W., Chen, J., Ali, N., Tian, J. H., & Zhang, W. (2026) · Nature Communications · doi:10.1038/s41467-026-71549-y · Cited by 3
“Cellular senescence is a fundamental pathological pathway for nearly all diseases and has inspired efforts to explore senescence for the treatment 1 – 3 .”
PERK drives aflatoxin B1-induced chicken cellular senescence by promoting NLRP3-mediated PANoptosis
Cheng, Y., Hu, Z.-Y., Si, H.-L., Wang, T.-H., Lou, M., Chen, M.-S., Wang, J.-X., Jiang, F.-W., Huang, Y.-F., Zheng, J., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.05.031 · Cited by 3
Mapping the evolution of liver aging research: A bibliometric analysis
Han, Q., Huang, S.-M., Wu, S., Luo, S.-S., Lou, Z.-Y., Li, H., Yang, Y., Zhang, Q., Shao, J., & Zhu, L. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i41.4461 · Cited by 3
Shi, J., Wu, X., Yu, J., & Zhou, Q. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1651357 · Cited by 2
Engineering Aging: Approaches to Model and Deconstruct Biological Complexity
Joukhdar, H., Lee, S. S., Cox, T. R., Choi, Y. S., Wise, S. G., Young, J. L., Yeo, G. C., & Lim, K. S. (2025) · Advanced Materials · doi:10.1002/adma.202512523 · Cited by 2
Integrative Omics Reveal Female‐Specific Benefits of p16 + Cell Clearance in Aging Mice
Lin, Y., Wang, B., Huang, M., Wolters, J. C., & Demaria, M. (2025) · Advanced Science · doi:10.1002/advs.202509444 · Cited by 2
Liver aging and associated diseases
Xu, Y., Deng, Q., Chen, Y., & Wang, H. (2026) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/csb-2025-5918 · Cited by 2
Vahdati, S. S., Sarmadian, P. J., Ala, A., Bagi, H. R. M., Gargari, S. O., & Sarmadian, A. J. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02323-w · Cited by 2
Redox rhythms promote fitness by modulating ageing-dependent reprogramming
Wang, X., Cui, S.-S., Li, X.-K., Qu, S., Chang, W., Tang, A., Jin, Y., Peng, S.-J., Wang, H.-P., Fang, X.-Q., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01515-x · Cited by 2
“The cumulative effect of cellular senescence and inflammaging compromises liver functions during ageing 39 .”
Cellular senescence: from pathogenic mechanisms to precision anti-aging interventions
Deng, J., Sun, R., Bai, Z., Fang, L., Zhao, X., & Yang, D. (2026) · Aging · doi:10.18632/aging.206375 · Cited by 2
“Given the ongoing controversy surrounding the origin and replacement rate of LSECs, the “seamless substitution” of these cells remains a primary concern [13, 14, 146].”
Padvitski, T., Avila, P. U., Chen, H., Özel, C., Braun, F., Kroll, M.-K., Vossen, C., Wienand, P., Butt, L., Unnersjö‐Jess, D., et al. (2026) · Cell Genomics · doi:10.1016/j.xgen.2026.101337 · Cited by 3
“94,95 The accumulation of hepatocyte senescence in MASLD has been shown to result in worse outcomes.”
Hu, H., Ji, R., & Hu, J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103321 · Cited by 2
Cellular senescence and its pathogenic and therapeutic implications in autoimmune hepatitis
Czaja, A. J. (2024) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2024.2432480 · Cited by 2
“Cellular senescence is characterized by the loss of replicative activity [1–4] and the development of a senescence-associated secretory phenotype (SASP) [5–13].”
The Biological Mechanisms of Frailty: Focusing on Cellular Senescence
Erusalimsky, J. D. (2026) · European Cardiology Review · doi:10.15420/ecr.2025.81 · Cited by 1
“72,73 These local changes cause systemic metabolic imbalances and impaired detoxification, which weaken physiological resilience.”
Santillan, C. M., Abbas, M., Macip, S., & Hanzu, F. A. (2026) · Endocrine Connections · doi:10.1530/ec-26-0197 · Cited by 1
Ding, Z., Fang, B., Peng, J., Wang, S., Tian, X., Chen, G., Wei, Y., Gao, Y., Li, Y., & Sun, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1787641 · Cited by 1
“While the populations of naive B cells and unswitched B cells were reduced, no alterations were observed in the numbers of other B cell subsets (Supplementary Figure 11).”
Li, M., Gao, C., Shi, Y., Peng, W., Yin, Y., Lü, B., & Fu, Z. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1745039 · Cited by 1
Qiu, X., Lu, Y., Tang, Y., Zhou, L., Lee, Y.-T., Meng, Z., Chen, Z., Pradeepa, F., Faccioli, L. A. P., Hu, Z., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci199303 · Cited by 1
“Recent studies have implicated cellular senescence as an emerging pathogenic factor in metabolic liver disease progression (25, 27).”
Zhao, W., JIAO, X., Du, K., Sun, Q., Duan, J., Cao, Y., Shen, X., Said, Z., Karri, S. S., Ellsworth, P. N., et al. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156630 · Cited by 1
Bile acids as a “new hormone” in aging-related liver disease
Deng, B., Li, X., Li, Y., Han, L., Zou, Z., Zhang, Y., Luo, J., Tang, X., Kong, H., Shi, C., et al. (2026) · Life Medicine · doi:10.1093/lifemedi/lnag030 · Cited by 1
Zhang, X., Fu, C., Yang, Z., Tan, Y., Li, H., Zhang, X., Chen, M., Peng, F., & Li, N. (2025) · Biomedicines · doi:10.3390/biomedicines13051249 · Cited by 1
Unmet needs in hepatology: The guidance of the Italian association for the study of the liver (AISF)
Gitto, S., Gabrielli, F., Addolorato, G., Tarli, C., Zaccherini, G., Calia, R., Germani, G., Burra, P., Zanetto, A., Ferri, F., et al. (2026) · Digestive and Liver Disease · doi:10.1016/j.dld.2025.12.016 · Cited by 1
Attema, B. J., & Kuipers, F. (2026) · Engineering · doi:10.1016/j.eng.2026.01.002 · Cited by 1
Bacillus amyloliquefaciens BA5 Attenuates Carbon Tetrachloride-Induced Hepatotoxicity in Mice
He, Y., Li, F., Li, Y., Xu, M., Quan, C., Nawaz, S., Kulyar, M. F., Iqbal, M., & Li, J. (2026) · Nutrients · doi:10.3390/nu18020298 · Cited by 1
Sexual Dimorphism in the Initial Apoptotic Switch During MASH Progression in Mice
Rajan, P. K., Sanabria, J., Schade, M. S., Udoh, U. S., Gorka, A., Sodhi, K., Pierre, S. V., & Sanabria, J. R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031501 · Cited by 2
Li, Z., Wei, S., Fu, G., Liu, R., Zhang, S., Liu, W., Pan, T., Zhang, Y., & Wen, X. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.157941 · Cited by 1
Marine Bioactives in Liver Aging: Mechanistic Insights and Translational Potential
Traspas, R. M., & Tman, Z. (2026) · Marine Drugs · doi:10.3390/md24040138 · Cited by 1
Gene therapy for aging: Current evidence and future directions
Zhang, Y. C., Gan, L., Wang, S., & Zhang, J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103144 · Cited by 1
Shao, Q., Chen, D., Shao, W., & Ye, Q. (2026) · Research · doi:10.34133/research.1326 · Cited by 1
“Cellular senescence, defined as an irreversible halt in cell division, is essential for normal tissue regeneration and cancer prevention [ 3 ].”
Exercise-induced mitochondrial remodeling in energy-demanding organs during aging
Zhou, Z., Gao, J., Wang, M., & Zhang, H. (2026) · iScience · doi:10.1016/j.isci.2026.116791 · Cited by 1
Liu, J., Sun, R., Huang, J., & Wang, C. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1919617 · Cited by 1
“However, liver diseases caused by viral infections, alcohol consumption, metabolic dysfunction, drug toxicity, and immune abnormalities have become major global public health challenges, seriously threatening human health (LeFort et al., 2024; Sanfeliu-Redondo et al., 2024).”
Tsouri, E., Athanasopoulou, N., Akkari, L., & Vegna, S. (2026) · Seminars in Immunology · doi:10.1016/j.smim.2026.102053 · Cited by 1
El‐Sehrawy, A. A. M. A., Radhie, S. H., Baig, M. R., Mansurov, D., M, R. M., Nayak, P. P., Bainsal, N., Singhal, D., Smerat, A., & Almajar, M. (2026) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2026.105031 · Cited by 1
The hepatic sinusoid as a regulatory niche: From cellular specialization to precision hepatology
Fernández‐Iglesias, A., Harris, E. N., Jalan‐Sakrikar, N., Kaur, S., Zapotoczny, B., Ikejima, K., & Gracia‐Sancho, J. (2026) · Hepatology · doi:10.1097/hep.0000000000001870 · Cited by 1
Self-citationHepatocyte senescence and persistent liver injury in Fanconi anemia
Koo, J., Snyder, A. J., Campbell, K. M., Miller, E., O’Conner, A., Grompe, M., Mehta, P. A., Myers, K. C., & Davies, S. M. (2025) · Haematologica · doi:10.3324/haematol.2024.287096
Lu, Y., Zhang, C., Wu, B., Guo, J., Fan, D., Wang, G., Zhang, W., Lin, L., Xu, X., Du, X., et al. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.137914
Enhancing Safety and Efficacy of Senolytic Therapies with Advanced Controlled Release StrategiesPreprint
Ferreira, L., Francisco, V., Marques, A., Sanfeliu-Redondo, D., Tomé, I., Rosa, S. C., Pitrez, J., Aristu-Zabalza, P., & Gracia‐Sancho, J. (2025) · Research Square · doi:10.21203/rs.3.rs-5442026/v1
Self-citationProteomics-based mechanism of HIIT regulation of hepatic metabolism in aging female rats
He, J., Wang, Z., Qiao, Y., Zhang, C., Yu, Z., Ni, P., Zhao, Z., Jianmei, C., & Li, F. (2025) · Biogerontology · doi:10.1007/s10522-025-10351-7
“These changes include reduced mitochondrial oxidative metabolism, decreased antioxidant defenses, and increased inflammation in the liver (Sanfeliu-Redondo et al. 2024).”
Transfer of Aging: Implications for Pediatric Solid Organ Transplantation
Gudenberg, R. W. V., Eckholt, L. S. J., Moosburner, S., Greve, D., Boerger, L., Walter, K. A., Wert, L., Geiger, D., Penkalla, A., Schmitto, J. D., et al. (2025) · Pediatric Transplantation · doi:10.1111/petr.70226
Zeng, Y., Zhang, K., & Wu, X. (2025) · Medicine · doi:10.1097/md.0000000000046673
“[24,25] Another finding of this study is that the proportion of males among HCV infected individuals is higher than that among uninfected individuals (63.08% vs 49.38%, P .001), which is primarily associated with the modes of HCV transmission.”
InfluentialLi, Z., Li, Y., Jiang, T., Wang, Y., & He, Z. (2026) · Biomedicines · doi:10.3390/biomedicines14030701
Huang, K., & Ren, J. P. (2026) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2025.33
Zhang, T., Ren, Z., Feng, F., Man, R., Shao, L., Zhang, H., Cheng, X., Gong, L., Peng, J., & Yu, Y. (2026) · The Innovation Life · doi:10.59717/j.xinn-life.2026.100179
Spatiotemporal Transcriptomics Characterizes Immune Microenvironment During Mouse Liver Aging
Lu, J., Wang, Y., Zhao, W. H., Zhao, Z., Gao, Z., Gu, J. F., Li, C., & Cheng, J. (2026) · Aging Cell · doi:10.1111/acel.70482
High altitude–mediated immune remodeling accelerates aging
Yu, X., Li, Y., Mao, Y., Jin, Z., Sun, M., Wang, X., Gan, Z., Song, Y., Li, J., Zhang, Z., et al. (2026) · Science Advances · doi:10.1126/sciadv.aeb5599
“Aging-associated hepatic dysfunction is marked by diminished regenerative capacity and progressive accumulation of senescent hepatocytes ( 48 ).”
Kerp, H., Siemes, D., Golchert, J., Homuth, G., Völker, U., Moeller, L. C., Engel, D. R., Führer, D., & Zwanziger, D. (2026) · Endocrine · doi:10.1007/s12020-026-04619-2
The p53/Mdm2 Pathway in Hepatocellular Carcinoma: From Molecular Pathogenesis to Targeted Therapies
Kirkness, K., & Mann, D. A. (2026) · Livers · doi:10.3390/livers6030039
Xu, Y., Li, M., Zhu, L., Luo, Y., Sheng, W., Jia, P., Suo, R., & Bao, L. (2026) · npj Science of Food · doi:10.1038/s41538-026-00904-6
“…molecular dysregulation fosters a pro-in fl ammatory hepatic microenvironment and aberrant ECM remodeling, which mechanistically contribute to hepatic stellate cell activation and the initiation of de novo fi brogenesis, thereby accelerating the onset and progression of liver fi brosis 19 .”
Diverse Forms of Autophagy and Their Roles in Liver Disease and Aging: A Comprehensive Review
Heo, S., Lee, M. Y., Jeong, C. Y., Kim, D. J., & Jun, J. H. (2026) · Proteomes · doi:10.3390/proteomes14020028
“Therefore, the accumulation of aged hepatocytes has been reported to influence the onset and progression of non-alcoholic fatty liver disease and viral hepatitis, thereby promoting liver injury, inflammation, fibrosis, and hepatocellular carcinoma [1].”
Metadata
- Authors
- Sanfeliu-Redondo, D., Gibert-Ramos, A., & Gracia-Sancho, J.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2024-03-14
- Volume
- 21
- Issue
- 7
- Pages
- 477-492
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W4392817758
- Cited by
- 117
- References
- 187
- Citations by year
- 2026: 65 · 2025: 42 · 2024: 10
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, chronic liver disease, hepatocellular carcinoma, senescence-associated secretory phenotype, senolytics, liver disease progression
- MeSH terms
- Aging, Humans, Liver, Liver Diseases, Cellular Senescence, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.